NewsCMSFriday, February 20, 2026 · February 20, 2026
CMS Issues Gene Therapy Coverage Guidance
WHY IT MATTERS
Payment innovation may remove the biggest barrier to gene therapy access.
CMS issued new guidance encouraging Medicare and Medicaid coverage of gene therapies with outcome-based payment models.
Related news
FDA
FDA Approves XTORO
XTORO (FINAFLOXACIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…
FDA
FDA Approves SABRIL
SABRIL (VIGABATRIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…